Zoetis Inc. Operating Lease Liability
Zoetis Inc. (ZTS) had Operating Lease Liability of $248.00 million as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-02-12
- 2025-12-31: Operating Lease, Liability $248.00M.
- 2024-12-31: Operating Lease, Liability $225.00M.
- 2023-12-31: Operating Lease, Liability $236.00M.
- 2022-12-31: Operating Lease, Liability $229.00M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $248.00M 10-K · filed 2026-02-12 |
| 2024-12-31 | $225.00M 10-K · filed 2025-02-13 |
| 2023-12-31 | $236.00M 10-K · filed 2024-02-13 |
| 2022-12-31 | $229.00M 10-K · filed 2023-02-14 |
| 2021-12-31 | $192.00M 10-K · filed 2023-02-14 |
| 2020-12-31 | $203.00M 10-K · filed 2022-02-15 |
| 2020-03-31 | $192.00M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $199.00M 10-K · filed 2021-02-16 |
| 2019-09-30 | $203.00M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $205.00M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $167.00M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $200.00M 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |